Coronavirus Latest News

Coronavirus: AstraZeneca revises vaccine effectiveness to 76 per cent in updated US trial data

British-Swedish drug maker AstraZeneca on Wednesday revised down by three percentage points the effectiveness of its Covid-19 vaccine after American authorities raised concerns that results reported from its US trial were outdated.The company now says its vaccine is 76 rather than 79 per cent effective at preventing any kind of symptomatic Covid-19.It remains 100 per cent effective against severe Covid-19, it added.British PM Boris Johnson gets first dose of AstraZeneca vaccineThe move came…

Read the original article at South China Morning Post

Related Articles

Back to top button